Al Mustansiriyah Journal of Pharmaceutical Sciences最新文献

筛选
英文 中文
Pharmaceutical cocrystal and their role in improving solid state properties of active pharmaceutical ingredients 药物共晶及其在改善活性药物成分固态性能中的作用
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-05-22 DOI: 10.32947/ajps.v23i2.1019
Ameera A Radhi, Iman S Jaafar, Noor S Jaafar, Sarah M Faisal
{"title":"Pharmaceutical cocrystal and their role in improving solid state properties of active pharmaceutical ingredients","authors":"Ameera A Radhi, Iman S Jaafar, Noor S Jaafar, Sarah M Faisal","doi":"10.32947/ajps.v23i2.1019","DOIUrl":"https://doi.org/10.32947/ajps.v23i2.1019","url":null,"abstract":"Cocrystallization is an emerging approach for improving physico-chemical characteristics of an active pharmaceutical ingredient (API) for instance dissolution rate, solubility, stability in addition to mechanical \u0000properties without affecting their therapeutic activity. It is of great importance when other approaches like salt or polymorph formation do not encounter the estimated targets. \u0000In this review article, an outline of pharmaceutical cocrystals will be presented, with highlighting on factors affecting cocrystallization which include ∆pKa, donors and acceptors hydrogen bonds, molecular recognition point, synthon forming functional groups flexibility, dicarboxylic acid coformers carbon chain length and solvent effect, as well as and the methods for cocrystal preparation. Additionally, cocrystal characterization, dissolution pattern as well as the commercially available products were discussed.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83543345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathological evaluation of docetaxel effects in treatment of rheumatoid arthritis induced in rat model 多西他赛治疗大鼠类风湿关节炎模型的组织病理学评价
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-05-22 DOI: 10.32947/ajps.v23i2.1018
Omar Mustafa Alghulami, Ghaith A. Jasim, Suzan Yousif Jasim**
{"title":"Histopathological evaluation of docetaxel effects in treatment of rheumatoid arthritis induced in rat model","authors":"Omar Mustafa Alghulami, Ghaith A. Jasim, Suzan Yousif Jasim**","doi":"10.32947/ajps.v23i2.1018","DOIUrl":"https://doi.org/10.32947/ajps.v23i2.1018","url":null,"abstract":"Rheumatoid arthritis is an immune-mediated condition that affects synovial joints. Synovial tissue, cartilage, bone, and less frequently extra-articular structures which in turn experience \u0000inflammatory changes. Paclitaxel's semi-synthetic equivalent, docetaxel, is an anti-neoplastic drug. Methotrexate is a treatment for early RA and may have a mildly negative impact on peptidyl arginine deiminase type 4 fluorescence test. However, 30% of patients fail to complete treatment within the first year due to resistance or side effects. The synovial membrane of Rheumatoid arthritis patient infiltrated with macrophages and neutrophils that express peptidyl arginine deiminase type 4 which their effect in rheumatoid arthritis pathogenesis lies in the generation of citrullinated neoepitopes that are Anti cyclic citrullinated peptide antibodies-targeted. \u0000The purpose of this study: was to assess the anti-inflammatory effects of docetaxel and methotrexate on the joint structure. \u0000Methods: Five groups of eight rats were formed from the 40 male Wister rats. Complete Freund’s adjuvant was injected subcutaneously into rats to induce the disease. The first group is control group which was the only group consists of (healthy untreated) rats. Second group was received complete Freund’s adjuvant. 0.5ml of ordinary saline was intraperitoneally administered to both the control and induction groups. Based on a preliminary experiment, the third group was given intraperitoneally 1 mg/kg/on alternative day docetaxel. The fourth group was given intraperitoneally 1 mg/kg/week of Methotrexate. Fifth group was given a half dose of both Methotrexate and docetaxel concurrently. Arthritis index was measured and Knee joint was histopathological examined. \u0000Results: significant Arthritis Index decrease in docetaxel group (p≤0.05). Significant lowering Histometric scoring (p≤0.05) in docetaxel, and Methotrexate group (cellular hyperplasia, formation of granulation tissue, infiltration of leukocytes, destroying of cartilage and intensity of erosion & Articular cartilage thickness) level in rats induced arthritis. Conclusion:  This study showed that docetaxel may have anti-arthritic effects through their significant lowering Histometric scoring(p≤0.05).","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"46 14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72561471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients 伊拉克癌症患者化疗药物奥氮平与三联止吐治疗引起恶心呕吐的疗效研究
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-05-22 DOI: 10.32947/ajps.v23i2.1013
Ghufran salah ahmed, Khadim ali khadim2, Nabeel mudheher talib
{"title":"Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients","authors":"Ghufran salah ahmed, Khadim ali khadim2, Nabeel mudheher talib","doi":"10.32947/ajps.v23i2.1013","DOIUrl":"https://doi.org/10.32947/ajps.v23i2.1013","url":null,"abstract":"Background:Chemotherapy-caused nausea and vomiting is a health problem in cancer patients. Olanzapine is used with serotonin receptor antagonists plus dexamethasone post Neurokinin 1 receptor antagonists as the antiemetic. \u0000Objective: The study aimed to determine the efficacy of (5 and 10) mg of olanzapine with antiemetic drugs against chemotherapy-induced nausea and vomiting. \u0000Methods: The study groups are Group S: received triple antiemetic therapy aprepitant at (1-3) day, dexamethasone at (1-4) day, and ondansetron only on the first day. Group O5: received olanzapine 5 mg with triple antiemetic therapy aprepitant (1-3) days, dexamethasone (1-4) day, ondansetron the first day, and olanzapine 5 mg (1-4) days. Group O10: received (olanzapine 10 mg with triple antiemetic therapy) aprepitant (1-3) days, dexamethasone (1-4) days, ondansetron day 1, and olanzapine 10 mg (1-4) days. The cancer was diagnosed by mamograph; the MAT score was used to control chemotherapy-caused nausea and vomiting. \u0000Results: Higher acute and delayed nausea was observed in group S than in groups O5 and O10. Overall, nausea control was increased in group S than in groups O5 and O10. There was no significant difference between the different study groups. \u0000Conclusion: Olanzapine 5 mg and 10 mg could treat nausea more than triple antiemetic in patients with nausea.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"95 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74838299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis, Characterization, ADME Study and Antimicrobial Evaluation of New 1,2,3-triazole Derivatives of 2-phenyl benzimidazole. 2-苯基苯并咪唑新型1,2,3-三唑衍生物的合成、表征、ADME研究及抗菌评价。
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-05-22 DOI: 10.32947/ajps.v23i2.1016
Asmaa Adnan Abdulnabi, Karima Fadhil Ali, Basma M.Abd Razik
{"title":"Synthesis, Characterization, ADME Study and Antimicrobial Evaluation of New 1,2,3-triazole Derivatives of 2-phenyl benzimidazole.","authors":"Asmaa Adnan Abdulnabi, Karima Fadhil Ali, Basma M.Abd Razik","doi":"10.32947/ajps.v23i2.1016","DOIUrl":"https://doi.org/10.32947/ajps.v23i2.1016","url":null,"abstract":"Novel 2-amino benzimidazole derivatives containing amide, azide and 1,2,3-triazole moieties have been synthesized. Compound 3 was synthesized by reaction of o-phenylenediamine with p-aminobenzoic acid. Compound 3 was converted into amide by treatment with chloroacetyl chloride to get compound 4. Compound 4 and sodium azide were combined to create compound which has an azide group. Compound 5 was converted into 1,2,3-triazole derivatives by treatment with acetylene derivatives. FTIR, 1H-NMR, and Mass spectra have been used to confirm the chemical structures of various substances. By using a technique called well diffusion agar, the final products were examined in vitro to predict activity against two kinds of gram-positive bacteria and two kinds of gram-negative bacteria as well as the antifungal activity against Candida albicans fungus. All the final products exhibited moderate to potent activity compared to Trimethoprim and Fluconazole as reference antibacterial and antifungal drugs respectively. Swiss ADME was also used to undertake ADME tests to determine the bioavailability, drug-likeness and topological polar surface area of the synthesized molecule. The results showed that every chemical tested was absorbed orally and followed the Lipinski rule.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"23 23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88647805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mucoadhesive Film Forming Spray for Buccal Drug Delivery: A Review 口腔给药用黏附成膜喷雾剂的研究进展
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-03-02 DOI: 10.32947/ajps.v23i1.994
Reem Wael Shahadha, Nidhal Khazaal Maraie
{"title":"Mucoadhesive Film Forming Spray for Buccal Drug Delivery: A Review","authors":"Reem Wael Shahadha, Nidhal Khazaal Maraie","doi":"10.32947/ajps.v23i1.994","DOIUrl":"https://doi.org/10.32947/ajps.v23i1.994","url":null,"abstract":"Film-forming sprays provide a number of advantages over conventional topical treatments, including equal medication distribution and dosing, increased bioavailability (increase local drug concentration), and less irritability (Dosing frequency). Polymers and excipients that improve the characteristics of preparations and increase the stability of active substances are the building blocks of mucoadhesive film-forming sprays. Films made from diverse combinations of polymer and excipient exhibited a wide range of characteristics. This reveiw examines the many types of polymers and excipients, the different types of sprayers, the different evaluations, as well as the essential criteria that are involved in defining the sprayability and film properties. This comes to the conclusion that natural and synthetic polymers with viscoelastic properties can both be employed to optimize the administration of buccal drugs.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79473552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severity of Symptoms and Mortality in Diabetic Patients with COVID- 19 Infection. Review 糖尿病合并COVID- 19感染患者的症状严重程度和死亡率审查
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-03-01 DOI: 10.32947/ajps.v23i1.991
Zahraa ALBasry, Abeer Abdulhadi Rashid, Shaymaa Hasan Abbas
{"title":"Severity of Symptoms and Mortality in Diabetic Patients with COVID- 19 Infection. Review","authors":"Zahraa ALBasry, Abeer Abdulhadi Rashid, Shaymaa Hasan Abbas","doi":"10.32947/ajps.v23i1.991","DOIUrl":"https://doi.org/10.32947/ajps.v23i1.991","url":null,"abstract":"Background: COVID-19 pneumonia is an illness that was spreading rapidly around the world and causes many deaths. Diabetes, is considered as a risk factor which adds severity and mortality to COVID-19 infected persons. There are many studies aiming to explain the \u0000 exact association between diabetes and COVID-19.  This review aims to link between diabetes and COVID-19 risk factors, discuss the  management of patients with diabetes and COVID-19 and  provide perception into the COVID-19 disease complications relevant to diabetes .In this  review, many scientific articles and reports about COVID- 19 and Type 2 DM were collected from different databases (e.g., PubMed, Google Scholar, and Web of Science) using keywords such as SARS-CoV2, COVID-19, TYPE 2 DM, Mortality, and CO-morbidities .The result  from this study found that diabetic patients has poor prognosis, severe symptoms, worsen outcomes, and the mortality rate is higher among COVID-19 patients who have diabetes mellitus. Many complications associated with diabetes like peripheral neuropathy and vascular insufficiency can make patients more susceptible to infections. One of the sever complication of Covid-19 infection is, the cytokine storm, that result in excessive release of inflammatory cytokines (TNF-a, IL-6, IL-10), and this may be aggravated by the inflammatory process together with the hyper-coagulable condition in diabetic patients. In conclusion: Hyperglycemia is established as risk factor for increased morbidity and mortality in covid 19 infection.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"61 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76417513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The most common route of administration used during COVID-19 COVID-19期间最常用的给药途径
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-03-01 DOI: 10.32947/ajps.v23i1.990
Mena Raid Khalil, Ghaidaa S. Hameed, Dalya Basil Hanna
{"title":"The most common route of administration used during COVID-19","authors":"Mena Raid Khalil, Ghaidaa S. Hameed, Dalya Basil Hanna","doi":"10.32947/ajps.v23i1.990","DOIUrl":"https://doi.org/10.32947/ajps.v23i1.990","url":null,"abstract":"The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the virus that caused the COVID-19 pandemic. Initial symptoms include fever, cough, and dyspnea. Symptoms include nausea, vomiting, and abdominal pain, GIT involvement is also possible. The COVID-19 outbreak has increased the need for alternative medicine administration routes, particularly in public places. Buccal, sublingual, and rectal administration are all considered transmucosal methods. They are self-administration options for non-invasive systemic distribution. In addition, they are great for use in palliative and end-of-life care because of their quick onset of action and decreased first-pass metabolism. A mucosal atomization device allows for the intranasal administration of a parenteral formulation through nasal spray. Rectal mucosal absorption is comparable to that of the oral route, making the rectal route an extremely versatile and useful method of drug administration for a wide variety of medications. Covid-19 illness is treated with a variety of drugs, including anti-malaria medication (hydroxychloroquine), glucocorticoids (dexamethasone), antibiotics (azithromycin), and antiviral medications (favipiravir). This article discusses the route of drug administration for COVID-19, as well as symptoms, treatments, and the various ways it can be spread","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78039173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathological evaluation of induced pulmonary fibrosis under the effect of montelukast 孟鲁司特作用下诱导肺纤维化的组织病理学评价
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-02-28 DOI: 10.32947/ajps.v23i1.982
Mohammed Rabah Mahdi, Wassan Abdul Kareem Abbas, Ghaith Ali Jasim
{"title":"Histopathological evaluation of induced pulmonary fibrosis under the effect of montelukast","authors":"Mohammed Rabah Mahdi, Wassan Abdul Kareem Abbas, Ghaith Ali Jasim","doi":"10.32947/ajps.v23i1.982","DOIUrl":"https://doi.org/10.32947/ajps.v23i1.982","url":null,"abstract":"Pulmonary fibrosis (PF) is an interstitial lung disease leading to scarring of the lung. There are several types of lung fibrosis as familial pulmonary fibrosis, idiopathic pulmonary fibrosis, and others associated with non-specific \u0000  \u0000interstitial pneumonia. The most common type is idiopathic pulmonary fibrosis which is an unknown cause. Lung fibrosis causes changes in the histology of the lung by the disappearance of the lung parenchyma, replaced by an inflammatory infiltrate, and mild thickening of the pulmonary artery. The management of pulmonary fibrosis included Azathioprine, corticosteroid, and N-acetyl cysteinyl in 2011 but in 2014 this guideline was removed and replaced by nintedanib and pirfenidone. This study used Pirfenidone, as standard therapy for the treatment of pulmonary fibrosis, and montelukast is Cysteinyl leukotrienes (CysLT) antagonist which binds to its receptor (CysLTE4) located on smooth muscle cells of the respiratory airway causing anti-inflammatory effect by inhibition of inflammatory markers as TGFβ1. Sixty male rats were divided into five groups,12 rats for each group where the control group received distilled water by gastric gavage, the induction group received bleomycin intratracheally as a single dose, the pirfenidone group received pirfenidone 50mg/kg, montelukast group received montelukast 20mg/kg and the combination group received a half dose of pirfenidone and montelukast. After twenty-eight days after the treatment with montelukast or pirfenidone sacrifice rats and collect the organ (lungs) from each group were then placed in buffer formalin 10% for histopathological study. After 14 days from bleomycin dose, results show that bleomycin cause massive disappearance of pulmonary parenchyma that was replaced by an inflammatory infiltrate and medial thickening of the pulmonary artery in all groups, but montelukast and pirfenidone show normal lung paranchyma and pulmonary artery after 28 days of treatment in pirfenidone, montelukast, and combination groups. \u0000In conclusion, that bleomycin changes the histology of the lung causing induction of lung fibrosis in all groups after 14 days except control group but pirfenidone, montelukast, and combination of half dose of pirfenidone with a half dose of montelukast return the lung to normal architecture after 28 days of treatment.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"89 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76847218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Matrix Metalloproteinase-2: A Possible Link between COVID-19 and Periodontitis 血清基质金属蛋白酶-2:COVID-19与牙周炎的可能联系
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-02-28 DOI: 10.32947/ajps.v23i1.985
Suhad Jumaa Abd-Alkareem, Saad Hikmat Abdullah, Noor Dhia Hasan
{"title":"Serum Matrix Metalloproteinase-2: A Possible Link between COVID-19 and Periodontitis","authors":"Suhad Jumaa Abd-Alkareem, Saad Hikmat Abdullah, Noor Dhia Hasan","doi":"10.32947/ajps.v23i1.985","DOIUrl":"https://doi.org/10.32947/ajps.v23i1.985","url":null,"abstract":"Background: Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  It is a severe infection primarily targeting the respiratory system. However, many other extrapulmonary body organs are also \u0000affected with a varying degree of severity. Some evidence indicated the development of periodontist in patients, although the pathogenesis is not well-defined. \u0000Aims: This study aimed to investigate the association of COVID-19 severity and role of matrix metalloproteinase 2 in development of periodontitis. \u0000Patients and Methods: This is a cross sectional study which included a total of 160 patients with COVID-19. Patients were categorized into severe and mild-moderated according to World Health Organization criteria. Periodontitis was diagnosed in those patients according to clinical criteria. Serum level of matrix metalloproteinase 2 was estimated in all patients using enzyme linked immunosorbent assay (ELISA). Demographic and laboratory data were obtained from the patients’ records. \u0000Results: Forty-two patients (26.25%) had severe COVID-19. Demographically, older ages and the presence of comorbidities were significantly associated with COVID-19 severity. Besides the inflammatory markers, the median serum level of MMP-2 was higher in severe than mild-moderate COVID-19 cases (208.12 ng/ml vs. 196.33 ng/ml) with a significant difference. The PO rate in severe and mild-moderate COVID-19 was 23.81% and 10.17%, respectively, with a significant difference. The median serum MMP-2 in patients with PO was 228.5 ng/ml which was significantly higher than those without PO 193.81 ng/ml. \u0000Conclusions: These data indicate the significant association between COVID-19 severity and development of PO. Matrix metalloproteinase-2 could be the possible link between severe COVID-19 and PO.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79741458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Insights into medicated films as attractive dosage forms 洞察药物薄膜作为有吸引力的剂型
Al Mustansiriyah Journal of Pharmaceutical Sciences Pub Date : 2023-02-28 DOI: 10.32947/ajps.v23i1.981
Noor Hameed Alsaide, Nidhal Khazaal Maraie
{"title":"Insights into medicated films as attractive dosage forms","authors":"Noor Hameed Alsaide, Nidhal Khazaal Maraie","doi":"10.32947/ajps.v23i1.981","DOIUrl":"https://doi.org/10.32947/ajps.v23i1.981","url":null,"abstract":"Different traditional dosage forms available in the market with many drawbacks including patient inconvenience, limited applications to several sites, variable bioavailability in addition to patent expiration. These drawbacks make pharmaceutical companies look for other drug platforms. Thin films loaded with active ingredients which are prepared as flexible polymer layer gaining acceptability in drug industry. They are easily prepared, adapted for administration of drug via different routes (to overcome several barriers) including ocular, dermal, transdermal, vaginal, oral and others. In additions, thin films are free of harmful chemicals and offer good drug stability. This review spotlights on the medicated thin films as alternative dosage forms that require further attention to maximize their performance and application.","PeriodicalId":7406,"journal":{"name":"Al Mustansiriyah Journal of Pharmaceutical Sciences","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75727377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书